How Tradeable Subscription Rights Neutralize Share Dilution in Secondary Offerings

Corporate boards facing capital shortfalls must decide how to raise funds without destroying existing shareholder value. When a board authorizes a secondary offering, they typically price new shares at a steep discount to attract institutional buyers. This decision immediately dilutes the ownership stake of any retail investor excluded from the deal.[3]

To prevent this wealth transfer, boards can issue tradeable subscription rights instead of executing a direct placement. A rights offering grants every existing shareholder a short-term warrant to buy new shares at the discounted price. If a shareholder holds 1,000 shares, they receive 1,000 rights.[2]

The critical mechanism is that these rights trade independently on the open market before they expire. If a shareholder cannot afford to buy the new shares, they can sell the rights to someone who can. This secondary market for the rights themselves neutralizes the financial penalty of dilution.[2][4]

"By distributing tradeable rights, a company effectively compensates non-participating shareholders for the exact amount of equity dilution they suffer," notes the Securities and Exchange Commission in its 2026 investor bulletin. The math behind this compensation relies on a metric known as the Theoretical Ex-Rights Price, or TERP.[2]

The Mechanics of Dilution

Consider a publicly traded company with 10 million shares outstanding, trading at exactly $100 per share. The company possesses a total market capitalization of $1 billion. The board decides to raise $200 million in fresh capital to fund a major acquisition, requiring the issuance of new equity.[1]

To ensure the new shares sell quickly, the board prices them at $80 each, representing a 20% discount to the current market price. Raising $200 million at $80 per share requires issuing 2.5 million new shares. The total share count expands from 10 million to 12.5 million.[1]

If this were a standard secondary offering, institutional investors would buy the 2.5 million shares at $80, instantly capturing a $20 per share paper profit. The total value of the company becomes the original $1 billion plus the $200 million in new cash, totaling $1.2 billion.[3]

However, that $1.2 billion is now divided across 12.5 million shares. The new share price drops mathematically to $96. An existing retail shareholder who owned 100 shares just saw their portfolio value fall from $10,000 to $9,600, losing $400 to the institutional buyers.[1][3]

This $4 per share drop represents the structural dilution penalty inherent in discounted equity sales. Without a mechanism to capture the discount, existing shareholders permanently lose 4% of their portfolio value. Tradeable subscription rights exist specifically to plug this mathematical leak.[3][5]

Calculating the Theoretical Ex-Rights Price

Instead of selling directly to institutions, the board issues a 1-for-4 rights offering. Every shareholder receives one right for each share they own, and it takes four rights to purchase one new share at the $80 subscription price. The total number of new shares remains 2.5 million.[2]

The day the stock begins trading without the attached rights is known as the ex-rights date. On this morning, the market automatically adjusts the share price downward to reflect the impending influx of discounted shares. This adjusted baseline is the Theoretical Ex-Rights Price.

Calculating TERP requires blending the value of the existing shares with the value of the new shares. The formula adds the pre-issue market capitalization to the total capital raised, then divides that sum by the new total share count.

In this scenario, dividing the $1.2 billion total value by the 12.5 million total shares yields a TERP of exactly $96. This is the price at which the stock should theoretically trade the moment the rights detach. The $4 difference is the exact value of the dilution.[1]

"The ex-rights price represents a perfect weighted average of the old equity and the new capital," explains a 2025 working paper from the National Bureau of Economic Research. "It assumes frictionless markets where the cash raised immediately translates to enterprise value."[3]

The Value of the Right Itself

Because the stock will drop to $96, the right to buy a new share at $80 is inherently valuable. The intrinsic value of one new share purchased through the offering is the $96 market price minus the $80 subscription cost, equaling $16 of embedded profit.

However, it takes four rights to purchase that single new share under the 1-for-4 ratio. Therefore, the value of a single right is $16 divided by four, which equals $4. Uncoincidentally, this $4 perfectly matches the per-share drop from the original $100 stock price.[1]

This mathematical symmetry is the core function of a tradeable rights offering. The value lost in the underlying share price is exactly offset by the value gained in the newly issued derivative. The shareholder's total wealth remains entirely unchanged throughout the corporate action.[2][5]

A shareholder with 100 shares originally held $10,000 in equity. On the ex-rights date, they hold 100 shares worth $9,600, plus 100 tradeable rights worth $400. Their total portfolio value remains exactly $10,000, neutralizing the dilution penalty completely.[1]

The shareholder now faces a choice regarding their newly separated assets. They can exercise the rights by spending $800 to buy 10 new shares, or sell the 100 rights on the open market for $400 in cash. Both actions preserve their exact economic position.[2]

Why Non-Participating Shareholders Still Win

In a standard secondary offering, a shareholder who lacks the cash to buy more stock simply suffers the dilution. In a tradeable rights offering, the shareholder can sell their rights on the open exchange. This converts their dilution penalty into an immediate cash dividend.[3]

When the retail investor sells their 100 rights for $400, they are effectively selling their portion of the discounted offering to an institutional buyer. The institution pays $4 per right, needs four rights, and pays the $80 subscription price, totaling $96 per share.[1]

The institutional buyer ends up paying the exact Theoretical Ex-Rights Price for the new equity. They receive no discount at the expense of the retail investor. The $400 wealth transfer that would have occurred in a direct placement is intercepted and returned to the original shareholder.[3][5]

"Tradeable rights democratize the institutional discount," notes the Corporate Finance Institute in its 2026 valuation guidelines. "They force new capital to compensate existing capital for the privilege of entry, rather than allowing new capital to extract a toll."

If a shareholder simply ignores the offering and lets the rights expire worthless, they will suffer the full $400 loss. To prevent this, many modern brokerages automatically sell unexercised rights on the final day of trading. This credits the cash directly to the client's account.[2][4]

Market Frictions and Arbitrage

While the math is perfectly symmetrical on paper, real-world trading introduces friction. The actual market price of the rights rarely matches the theoretical $4 exactly. Volatility in the underlying stock price constantly shifts the value of the embedded discount during the trading window.[4][5]

If the company's stock drops to $90 during the offering period, the TERP recalculates, and the value of the rights collapses. If the stock drops below the $80 subscription price, the rights become entirely worthless. In that scenario, the capital raise will likely fail.[4]

To prevent failed offerings, boards typically hire investment banks to act as underwriters. The underwriters agree to purchase any unsold shares at the $80 subscription price. This backstop guarantees the company receives its $200 million regardless of market fluctuations.[5]

Arbitrageurs actively trade the spread between the rights and the stock to maintain pricing efficiency. If the rights trade at $3.80 while theoretical value is $4.00, hedge funds will buy the rights and short the stock. This locks in a risk-free profit and forces prices back into alignment.[4][5]

Ultimately, the tradeable rights mechanism remains the most equitable method of raising corporate capital. By unbundling the discount from the share and pricing it as a separate asset, boards ensure fairness. Dilution only penalizes those who actively choose to throw their rights away.[1][3]